HIGHLIGHTS
- who: J Antimicrob Chemother et al. from the Department of Clinical Microbiology, Royal College of Surgeons in Ireland, Beaumont Hospital, Dublin, Ireland have published the Article: 5-Hydroxyethyl-3-tetradecanoyltetramic acid represents a novel treatment for intravascular catheter infections due to Staphylococcus aureus, in the Journal: (JOURNAL) of 24/06/2016
- how: The authors investigated the antibacterial activity cytotoxicity and CLS potential of_(5HE-C14-TMA) compared with the related compounds 3-tetradecanoyltetronic (C14-TOA) and 3-tetradecanoylthiotetronic (C14-TTA) which are variants of quorum sensing signalling molecules produced by Pseudomonas aeruginosa. Given the need . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.